Starling Oncology, Inc. Amortization of Debt Issuance Costs and Discounts
Starling Oncology, Inc. (DFPH) reported Amortization of Debt Issuance Costs and Discounts of $4.63 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-11-08
- 2023-09-30: Amortization of Debt Issuance Costs and Discounts 9 month $4.63M.
- 2022-09-30: Amortization of Debt Issuance Costs and Discounts 9 month $892.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 9 month |
|---|---|
| 2023-09-30 | $4.63M 10-Q · filed 2023-11-08 |
| 2022-09-30 | $892.00K 10-Q · filed 2023-11-08 |